Schrödinger FY2024 EPS Estimate Lowered by Leerink Partnrs

Schrödinger, Inc. (NASDAQ:SDGR) – Equities researchers at Leerink Partnrs reduced their FY2024 earnings estimates for Schrödinger in a research report issued on Wednesday, January 22nd. Leerink Partnrs analyst M. Foroohar now expects that the company will earn ($2.11) per share for the year, down from their previous estimate of ($1.99). The consensus estimate for Schrödinger’s current full-year earnings is ($2.29) per share. Leerink Partnrs also issued estimates for Schrödinger’s Q4 2024 earnings at ($0.09) EPS, FY2025 earnings at ($2.16) EPS and FY2026 earnings at ($2.73) EPS.

Other research analysts have also issued reports about the company. BMO Capital Markets raised their price objective on Schrödinger from $25.00 to $28.00 and gave the company an “outperform” rating in a research report on Wednesday, November 13th. KeyCorp boosted their price target on Schrödinger from $25.00 to $27.00 and gave the stock an “overweight” rating in a research note on Friday. Three equities research analysts have rated the stock with a hold rating, seven have given a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $33.10.

Schrödinger Trading Up 1.1 %

Shares of SDGR stock opened at $24.67 on Friday. The company has a market cap of $1.80 billion, a PE ratio of -10.54 and a beta of 1.59. The company’s fifty day simple moving average is $20.71 and its 200-day simple moving average is $20.08. Schrödinger has a 52 week low of $16.67 and a 52 week high of $33.63.

Schrödinger (NASDAQ:SDGR) last posted its earnings results on Tuesday, November 12th. The company reported ($0.52) earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.12). The business had revenue of $35.30 million for the quarter, compared to analyst estimates of $41.25 million. Schrödinger had a negative return on equity of 35.77% and a negative net margin of 91.84%. The firm’s revenue for the quarter was down 17.1% compared to the same quarter last year. During the same period last year, the company posted ($0.86) EPS.

Institutional Trading of Schrödinger

Institutional investors and hedge funds have recently modified their holdings of the business. Avanza Fonder AB bought a new stake in shares of Schrödinger during the 4th quarter valued at about $577,000. Stephens Investment Management Group LLC grew its holdings in shares of Schrödinger by 39.6% during the third quarter. Stephens Investment Management Group LLC now owns 1,539,870 shares of the company’s stock valued at $28,565,000 after purchasing an additional 436,789 shares during the last quarter. Barclays PLC grew its holdings in shares of Schrödinger by 421.6% during the third quarter. Barclays PLC now owns 107,554 shares of the company’s stock valued at $1,995,000 after purchasing an additional 86,933 shares during the last quarter. Millennium Management LLC raised its position in shares of Schrödinger by 2,868.8% during the 2nd quarter. Millennium Management LLC now owns 487,831 shares of the company’s stock worth $9,435,000 after purchasing an additional 471,399 shares during the period. Finally, State Street Corp lifted its holdings in shares of Schrödinger by 1.8% in the 3rd quarter. State Street Corp now owns 2,155,620 shares of the company’s stock worth $39,987,000 after purchasing an additional 38,972 shares during the last quarter. 79.05% of the stock is owned by institutional investors and hedge funds.

About Schrödinger

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.